New York State Teachers Retirement System Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

New York State Teachers Retirement System decreased its holdings in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 0.6% in the fourth quarter, Holdings Channel reports. The fund owned 117,159 shares of the company’s stock after selling 733 shares during the period. New York State Teachers Retirement System’s holdings in Henry Schein were worth $8,107,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in HSIC. ING Groep NV acquired a new stake in shares of Henry Schein in the third quarter valued at approximately $63,226,000. Holocene Advisors LP purchased a new stake in Henry Schein in the 3rd quarter valued at $58,319,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Henry Schein in the 3rd quarter worth $43,740,000. Southpoint Capital Advisors LP raised its holdings in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after acquiring an additional 600,000 shares during the period. Finally, Bank of Montreal Can boosted its position in shares of Henry Schein by 365.6% during the 3rd quarter. Bank of Montreal Can now owns 711,487 shares of the company’s stock valued at $52,095,000 after acquiring an additional 558,689 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $77.63 on Wednesday. The stock has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The business has a 50-day moving average of $74.03 and a 200 day moving average of $72.02. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63.

Analysts Set New Price Targets

A number of equities analysts have commented on HSIC shares. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. Jefferies Financial Group increased their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Barrington Research increased their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $80.09.

Check Out Our Latest Research Report on Henry Schein

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.